Cargando…

Disease risk analysis for schizophrenia patients by an automatic AHP framework

BACKGROUND: Based on more than 15 million follow-up records of 404,426 patients from Guangdong Mental Health Center over the past 10 years, this study aims to propose a disease risk analysis and prediction model to support chronic disease management and clinical research for schizophrenia patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Wenyan, Weng, Heng, Lin, Haicheng, Ou, Aihua, He, Zehui, Jia, Fujun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750858/
https://www.ncbi.nlm.nih.gov/pubmed/35016654
http://dx.doi.org/10.1186/s12911-022-01749-1
_version_ 1784631555823501312
author Tan, Wenyan
Weng, Heng
Lin, Haicheng
Ou, Aihua
He, Zehui
Jia, Fujun
author_facet Tan, Wenyan
Weng, Heng
Lin, Haicheng
Ou, Aihua
He, Zehui
Jia, Fujun
author_sort Tan, Wenyan
collection PubMed
description BACKGROUND: Based on more than 15 million follow-up records of 404,426 patients from Guangdong Mental Health Center over the past 10 years, this study aims to propose a disease risk analysis and prediction model to support chronic disease management and clinical research for schizophrenia patients. METHODS: Based on a mental health information and intelligent data processing platform, we design an automatic AHP framework called AutoAHP to analyze and predict the disease risks of schizophrenia patients. Through automatic extraction, transformation and integration of follow-up data in the real world such as demography, treatment, and the disease course, a chronic database of patient status is established. In combination with age-period-cohort, logistic regression and Cox models, we apply the AutoAHP to assess disease risk and implement risk prediction in practice. RESULTS: A list of essential factors for risk prediction are identified, including annual changes in mental health policy, public support, regional difference, patient gender, compliance, and social function. After the verification of 1,222,038 complete disease course and treatment records of 256,050 patients, the AutoAHP framework achieves a precision of 0.923, a recall of 0.924, and a F1 of 0.923. The model is demonstrated to be superior to general models and has better performance in risk prediction. CONCLUSIONS: Aiming at the risk assessment of patients with schizophrenia which is influenced by factors, such as time, region and complication, the AutoAHP framework is able to be applied as a model in combination with logistic regression and Cox models to support clinical analysis of disease risk related factors and assist decision-making in chronic disease management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-022-01749-1.
format Online
Article
Text
id pubmed-8750858
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87508582022-01-11 Disease risk analysis for schizophrenia patients by an automatic AHP framework Tan, Wenyan Weng, Heng Lin, Haicheng Ou, Aihua He, Zehui Jia, Fujun BMC Med Inform Decis Mak Research BACKGROUND: Based on more than 15 million follow-up records of 404,426 patients from Guangdong Mental Health Center over the past 10 years, this study aims to propose a disease risk analysis and prediction model to support chronic disease management and clinical research for schizophrenia patients. METHODS: Based on a mental health information and intelligent data processing platform, we design an automatic AHP framework called AutoAHP to analyze and predict the disease risks of schizophrenia patients. Through automatic extraction, transformation and integration of follow-up data in the real world such as demography, treatment, and the disease course, a chronic database of patient status is established. In combination with age-period-cohort, logistic regression and Cox models, we apply the AutoAHP to assess disease risk and implement risk prediction in practice. RESULTS: A list of essential factors for risk prediction are identified, including annual changes in mental health policy, public support, regional difference, patient gender, compliance, and social function. After the verification of 1,222,038 complete disease course and treatment records of 256,050 patients, the AutoAHP framework achieves a precision of 0.923, a recall of 0.924, and a F1 of 0.923. The model is demonstrated to be superior to general models and has better performance in risk prediction. CONCLUSIONS: Aiming at the risk assessment of patients with schizophrenia which is influenced by factors, such as time, region and complication, the AutoAHP framework is able to be applied as a model in combination with logistic regression and Cox models to support clinical analysis of disease risk related factors and assist decision-making in chronic disease management. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12911-022-01749-1. BioMed Central 2022-01-11 /pmc/articles/PMC8750858/ /pubmed/35016654 http://dx.doi.org/10.1186/s12911-022-01749-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tan, Wenyan
Weng, Heng
Lin, Haicheng
Ou, Aihua
He, Zehui
Jia, Fujun
Disease risk analysis for schizophrenia patients by an automatic AHP framework
title Disease risk analysis for schizophrenia patients by an automatic AHP framework
title_full Disease risk analysis for schizophrenia patients by an automatic AHP framework
title_fullStr Disease risk analysis for schizophrenia patients by an automatic AHP framework
title_full_unstemmed Disease risk analysis for schizophrenia patients by an automatic AHP framework
title_short Disease risk analysis for schizophrenia patients by an automatic AHP framework
title_sort disease risk analysis for schizophrenia patients by an automatic ahp framework
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750858/
https://www.ncbi.nlm.nih.gov/pubmed/35016654
http://dx.doi.org/10.1186/s12911-022-01749-1
work_keys_str_mv AT tanwenyan diseaseriskanalysisforschizophreniapatientsbyanautomaticahpframework
AT wengheng diseaseriskanalysisforschizophreniapatientsbyanautomaticahpframework
AT linhaicheng diseaseriskanalysisforschizophreniapatientsbyanautomaticahpframework
AT ouaihua diseaseriskanalysisforschizophreniapatientsbyanautomaticahpframework
AT hezehui diseaseriskanalysisforschizophreniapatientsbyanautomaticahpframework
AT jiafujun diseaseriskanalysisforschizophreniapatientsbyanautomaticahpframework